Small-vessel vasculitis after ST-segment elevation myocardial infarction
Abstract: We report a case of cutaneous small-vessel vasculitis in a patient treated with clopidogrel after an ST-segment elevation myocardial infarction and with amiodarone caused by persistent atrial fibrillation 6 weeks before. (Level of Difficulty: Intermediate.)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
JACC: case reports. - 4, 15 (2022) , 967-971, ISSN: 2666-0849
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2022
- Creator
- DOI
-
10.1016/j.jaccas.2022.05.008
- URN
-
urn:nbn:de:bsz:25-freidok-2290706
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lehr, Saskia
- Meiß, Frank
- Kiritsi, Dimitra
- Tsakiris, Leonidas
- Universität
Time of origin
- 2022
Other Objects (12)
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Plectin in skin fragility disorders
Inborn errors of immunity and immunodeficiencies: Antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions
Recent advances in understanding and managing epidermolysis bullosa
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Treatment of Epidermolysis bullosa acquisita with dupilumab
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Plectin in skin fragility disorders
Inborn errors of immunity and immunodeficiencies: Antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions
Recent advances in understanding and managing epidermolysis bullosa
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Treatment of Epidermolysis bullosa acquisita with dupilumab
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Plectin in skin fragility disorders
Inborn errors of immunity and immunodeficiencies: Antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions
Recent advances in understanding and managing epidermolysis bullosa
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Treatment of Epidermolysis bullosa acquisita with dupilumab